Pyrazol-3-carboxamide derivative (I) in amorphous form comprising surinabant and rimonabant form, is new. Independent claims are included for: (1) amorphous solid solution comprising (I) or its salts and/or solvate, with more excipient stabilizers themselves in amorphous form； (2) a preparation of the amorphous solid solution comprising dissolving (I) in the amorphous or crystalline form and excipient stabilizer in a appropriate solvent to form a liquid solution, and eliminating the solvent； and (3) a pharmaceutical composition comprising the amorphous solid solution.
